Attenuation of acute lung injury caused by hind-limb ischemia-reperfusion injury by butyrolactone anti-inflammatory agent FL1003... including commentary by Arrillaga A and Borzotta AP.

MLA

Cohen SM, et al. “Attenuation of Acute Lung Injury Caused by Hind-Limb Ischemia-Reperfusion Injury by Butyrolactone Anti-Inflammatory Agent FL1003... Including Commentary by Arrillaga A and Borzotta AP.” Journal of Trauma, vol. 43, no. 2, Aug. 1997, pp. 247–52. EBSCOhost, https://doi.org/10.1097/00005373-199708000-00007.

APA

Cohen SM, Siddiqi FA, Darakchiev B, Fantini GA, Hariri RJ, & Barie PS. (1997). Attenuation of acute lung injury caused by hind-limb ischemia-reperfusion injury by butyrolactone anti-inflammatory agent FL1003... including commentary by Arrillaga A and Borzotta AP. Journal of Trauma, 43(2), 247–252. https://doi.org/10.1097/00005373-199708000-00007

Chicago

Cohen SM, Siddiqi FA, Darakchiev B, Fantini GA, Hariri RJ, and Barie PS. 1997. “Attenuation of Acute Lung Injury Caused by Hind-Limb Ischemia-Reperfusion Injury by Butyrolactone Anti-Inflammatory Agent FL1003... Including Commentary by Arrillaga A and Borzotta AP.” Journal of Trauma 43 (2): 247–52. doi:10.1097/00005373-199708000-00007.